Comparing the effectiveness of Hepa-Mertz mono therapy versus rifaximin in patients presenting with hepatic encephalopathy

被引：0
|
作者：
Doyle, J. B. M. [1 ]
McDougall, N. I. [1 ]
Cash, W. J. [1 ]
机构：
[1] Royal Victoria Hosp, Liver Unit, Belfast BT12 6BA, Antrim, North Ireland
来源：
IRISH JOURNAL OF MEDICAL SCIENCE | 2015年 / 184卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
32(14S161)
引用
收藏
页码：S86 / S86
页数：1
相关论文
共 48 条
  • [21] RIFAXIMIN AND LACTULOSE COMBINATION THERAPY VERSUS LACTULOSE ALONE FOR PREVENTION OF OVERT HEPATIC ENCEPHALOPATHY RECURRENCE: A POOLED ANALYSIS OF TWO RANDOMIZED TRIALS
    Bajaj, Jasmohan S.
    Heimanson, Zeev
    Israel, Robert
    GASTROENTEROLOGY, 2019, 156 (06) : S560 - S560
  • [22] Hospitalizations and healthcare costs associated with rifaximin versus lactulose treatment among commercially insured patients with hepatic encephalopathy in the United States
    Volk, Michael L.
    Burne, Rebecca
    Guerin, Annie
    Shi, Sherry
    Joseph, George J.
    Heimanson, Zeev
    Ahmad, Maliha
    JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 202 - 211
  • [23] PROPHYLAXIS OF HEPATIC ENCEPHALOPATHY IN ACUTE VARICEAL BLEED IN PATIENTS WITH CIRRHOSIS: AN OPEN LABEL RANDOMIZED CONTROLLED TRIAL OF LACTULOSE VERSUS RIFAXIMIN
    Maharshi, S.
    Sharma, B. C.
    Srivastava, S.
    Jindal, A.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S9 - S9
  • [24] A RANDOMIZED TRIPLE BLIND, PLACEBO- CONTROLLED TRIAL TO DETERMINE EFFECTIVENESS OF RIFAXIMIN IN PREVENTING HEPATIC ENCEPHALOPATHY IN PATIENTS WITH CHRONIC LIVER DISEASE
    Aqeel, Abdur Rehman
    Butt, Binyamin
    Naveed, Hira
    Arshad, Ali
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (04): : 2728 - 2732
  • [25] Changes in the Body Composition and Nutritional Status after Long-term Rifaximin Therapy for Hyperammonemia in Japanese Patients with Hepatic Encephalopathy
    Ishikawa, Toru
    Endo, Saori
    Imai, Michitaka
    Azumi, Motoi
    Nozawa, Yujiro
    Sano, Tomoe
    Iwanaga, Akito
    Honma, Terasu
    Yoshida, Toshiaki
    INTERNAL MEDICINE, 2020, 59 (20) : 2465 - 2469
  • [26] COMPARATIVE STUDY OF RIFAXIMIN ENEMA VERSUS LACTULOSE ENEMA FOR THE TREATMENT OF CIRRHOTIC PATIENTS WITH WEST HAVEN GRADE I & II HEPATIC ENCEPHALOPATHY
    Radwan, Mohammed S.
    Elfert, Asem A.
    Amer, Ibrahim
    Elfert, Amr
    Hussien, Mohammed
    Elbatea, Hasan
    GASTROENTEROLOGY, 2023, 164 (06) : S1355 - S1356
  • [27] Comparative Analysis of the Efficacy of Different Regimens of 12 Months Rifaximin-Alfa Therapy in Patients with Liver Cirrhosis and Minimal Hepatic Encephalopathy
    Bakulin, Igor G.
    Ivanova, Kristina N.
    Eremina, Elena Y.
    Marchenko, Natalya V.
    DIAGNOSTICS, 2023, 13 (20)
  • [28] Reversal of Low-Grade Cerebral Edema After Lactulose/Rifaximin Therapy in Patients With Cirrhosis Who Have Minimal Hepatic Encephalopathy
    Dhiman, Radha
    Rai, Rahul
    Ahuja, Chirag
    Kalra, Navin
    Khandelwal, Niranjan
    Duseja, Ajay
    Chawla, Yogesh
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S156 - S156
  • [29] Assessment of Potential Impact of Demographic and Baseline Disease Characteristics on Rifaximin Monotherapy versus Lactulose Combination Therapy for the Prevention of Overt Hepatic Encephalopathy (OHE) Recurrence
    Flamm, Steven
    Mullen, Kevin
    Heimanson, Zeev
    Sanyal, Arun
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S494 - S494
  • [30] RIFAXIMIN VERSUS LACTULOSE IN THE TREATMENT OF MINIMAL HEPATIC ENCEPHALOPATHY IN PATIENTS WITH CIRRHOSIS: A PROSPECTIVE, RANDOMIZED, ACTIVE-COMPARATOR, NON-INFERIORITY TRIAL
    Goyal, O.
    Sidhu, S. S.
    Parker, R. A.
    Prasad, J.
    Kishore, H.
    Sood, A.
    Mehta, V.
    Chhina, R. S.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S526 - S526
12345